| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/21/2006 | CN1259963C Rosa roxburghii oral liquid and its preparing method |
| 06/21/2006 | CN1259954C Pills for dispelling stasis toxin and reducing retention of sputum |
| 06/21/2006 | CN1259920C Biologically active agents and drugs |
| 06/21/2006 | CN1259902C Process for producing nanoparticles of paclitaxel and albumin |
| 06/20/2006 | US7064218 Aromatic compounds and poly(oxyalkylene) containing aromatic compounds possessing antibacterial, antifungal or antitumor activity |
| 06/20/2006 | US7064217 2-Aminoacetamide derivatives with hydroxy-, phosphonate-, and/or methylene phosphonate substituent; antitumor, anticoagulant, antiproliferative, and wound healing agents |
| 06/20/2006 | US7064215 Nitrogen compounds such as 3-(5-morpholin-4-yl-1H-benz-imidazol-2-yl)-1H-indazole and/or isomers, used as immunology modulators, antidiabetic agents, antiogenesis inhibitors or for prophylaxis of Alzheimer's disease |
| 06/20/2006 | US7064204 Nitrogen compounds such as 4-(5-amino-7-phenethyl-7H-pyrazolo (4,3-e)(1,2,4)triazolo(1,5-c)pyrimidin-2-yl)-phenol, used as adenosine receptor antagonists, for prophylaxis of nervous, cardiovascular, respiratory, urogenital and immune disorders |
| 06/20/2006 | US7064203 Di-substituted pyrrolotriazine compounds |
| 06/20/2006 | US7064201 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
| 06/20/2006 | US7064193 Therapeutic molecules |
| 06/20/2006 | US7064190 An isolated complex of a peptide of glutamic acid decarboxylase(with specific 6 contiguous amino acids), and an allele of MHC class II molecules DR3 and DR4; useful for diagnosis and therapy of autoimmune diseases |
| 06/20/2006 | US7064189 Antibodies that immunospecifically bind to trail receptors |
| 06/20/2006 | US7064186 Comprises chemokine polypeptides for diagnosis, prevention and treatment of cell proliferative, immunological and hematopoietic disorders |
| 06/20/2006 | US7064185 Antibody for human Cyr61 |
| 06/20/2006 | US7064136 Central nervous system disorders; psychological disorders; schizophrenia; antiarthritic agents; Alzheimer's disease; anticancer agents |
| 06/20/2006 | US7064131 Compounds and methods for inhibiting MRP1 |
| 06/20/2006 | US7064125 LPAAT-β inhibitors and uses thereof |
| 06/20/2006 | US7064117 Anti-cancer 2,3-dihydro-1H-pyrrolo[3,2-f]quinoline complexes of cobalt and chromium |
| 06/20/2006 | US7064115 (20S)-1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses |
| 06/20/2006 | US7064112 selectively inhibiting abnormal cell proliferation by administering an A3-selective adenosine A3 receptor agonist in an amount of less than 100 mu g/Kg body weight. |
| 06/20/2006 | US7063973 HDAC9 polypeptides and polynucleotides and uses thereof |
| 06/20/2006 | US7063860 Bladder therapy; antiinflammatory agents |
| 06/20/2006 | US7063845 Human anti-CD40 antibodies |
| 06/20/2006 | US7063835 Virus strains |
| 06/20/2006 | CA2388334C Thermosensitive cyclotriphosphazene-platinum complex conjugate, its preparation method and anticancer agent containing the same |
| 06/20/2006 | CA2177392C Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
| 06/15/2006 | WO2006063294A2 Novel inhibitors of histone deacetylase for the treatment of disease |
| 06/15/2006 | WO2006063033A2 Aryl amide sphingosine 1-phosphate analogs |
| 06/15/2006 | WO2006062580A1 Indane amides with antiproliferative activity |
| 06/15/2006 | WO2006062173A1 Bcl-xL HETERODIMER INHIBITORY PEPTIDE ENHANCING THE EFFECT OF ANTICANCER AGENT AND METHOD OF SCREENING THE SAME |
| 06/15/2006 | WO2006062104A1 Bacillus macroides strain and food using the same |
| 06/15/2006 | WO2006062094A1 Novel cancer antigen peptide and the use thereof |
| 06/15/2006 | WO2006062093A1 Novel anthranilic acid derivative or salt thereof |
| 06/15/2006 | WO2006062072A1 Remedy for cancer metastasis and cancer metastasis inhibitor |
| 06/15/2006 | WO2006061715A2 Methylene inhibitors of matrix metalloproteinase |
| 06/15/2006 | WO2006061712A2 Use of mek inhibitors in treating abnormal cell growth |
| 06/15/2006 | WO2006061585A1 Pyrrolidine compounds |
| 06/15/2006 | WO2006061417A2 Macrocyclic quinazole derivatives and their use as mtki |
| 06/15/2006 | WO2006061415A1 2,4 (4,6) pyrimidine derivatives |
| 06/15/2006 | WO2006061242A2 Use of pta peptides for stratification of individuals having cancer |
| 06/15/2006 | WO2006061212A1 3-(indolyl)-4-arylmaleimide derivatives and their use as angiogenesis inhibitors |
| 06/15/2006 | WO2006060885A1 7-(2-cyclohexylidene-ethylidene)-spiro[5.5]undecanes useful for making pharmaceutical compositions |
| 06/15/2006 | WO2006060884A1 7-(2-cyclohexylidene-ethylidene)-spiro[4.5]decanes |
| 06/15/2006 | WO2006060878A1 Methods and compositions for adoptive immunotherapy |
| 06/15/2006 | WO2006060853A1 Treatment for cancer |
| 06/15/2006 | WO2006044823A3 Heteroaryl-substituted alkyne compounds and method of use |
| 06/15/2006 | WO2006044573A3 Reversible inhibitors of s-adenosyl-l-homocysteine hydrolase and uses thereof |
| 06/15/2006 | WO2006044379A3 Novel curcumin analogues and uses thereof |
| 06/15/2006 | WO2006042479A9 Pharmaceutical composition and non dependence coffee comprising edible carboxylic acid and/or its acid salt and coffeine |
| 06/15/2006 | WO2006042103A3 Reversible inhibitors of cathepsin b |
| 06/15/2006 | WO2006018222A8 Hydrates and polymorphs of 4-[[(7r)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-4-6-oxo-2-piperidinyl]amino]-3-methoxy-n-(1-methyl-4-piperidinyl) benzamide, methods for the production thereof, and use thereof as medicaments |
| 06/15/2006 | WO2006018221A8 Dihydropteridinone infusion solution having a long shelf life |
| 06/15/2006 | WO2006010838A3 Products containing at least one anticancer active principle with low diffusion and an immunostimulatory active principle |
| 06/15/2006 | WO2005117986A3 Antibody drug conjugates and methods |
| 06/15/2006 | WO2005110399A3 Zinc-binding groups for metalloprotein inhibitors |
| 06/15/2006 | WO2005092380A3 Uses of anti-ctla-4 antibodies |
| 06/15/2006 | US20060130169 Transgenic non-human mammals that reproduce human pathologies of stem cell origins, such as chromosomal anomalies associated with chronic myeloid leukemia, B-cell acute lymphoblastic leukemia, T-cell acute or lymphoblastic leukemia, or with the migration of hematopoietic or embryonic stem calls. |
| 06/15/2006 | US20060130168 Using transgenic non-human mammals that reproduce human pathologies of stem cell origins, such as chromosomal anomalies associated with chronic myeloid leukemia, B-cell acute lymphoblastic leukemia, T-cell acute or lymphoblastic leukemia, or with the migration of hematopoietic or embryonic stem cells |
| 06/15/2006 | US20060130167 Transgenic non-human mammals as models for human pathologies of stem cell origin |
| 06/15/2006 | US20060130166 Transgenic non-human mammals as models for human pathologies of stem cell origin |
| 06/15/2006 | US20060130164 Toll/interleukin-1 receptor adapter protein (TIRAP) |
| 06/15/2006 | US20060128966 Thia-epothilone derivatives for the treatment of cancer |
| 06/15/2006 | US20060128785 diindole compounds as anticancer agents; potentiation; effective against estrogen-dependent, estrogen-independent, drug-resistant and/or metastasized cancers |
| 06/15/2006 | US20060128784 Bis-heteroaryl alkanes as therapeutic agents |
| 06/15/2006 | US20060128782 Pharmaceutical composition based on ketorolac or one of its salts pharmaceutically acceptable and use of ketorolac or its salts in pharmaceutical compositions |
| 06/15/2006 | US20060128780 Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| 06/15/2006 | US20060128776 Opioid receptor active compounds |
| 06/15/2006 | US20060128768 Furanthiazole derivatives as heparanase inhibitors |
| 06/15/2006 | US20060128762 Medicinal composition and method for treating malignant tumor and utilization thereof |
| 06/15/2006 | US20060128761 Novel triazole compounds as transforming growth factor (TGF) inhibitors |
| 06/15/2006 | US20060128757 Pyridine derivatives useful as cyclooxygenase inhibitor |
| 06/15/2006 | US20060128745 Chemical compounds |
| 06/15/2006 | US20060128743 Method of improving bioavailability of orally administered drugs, a method of screening for enhancers of such bioavailability and novel pharmaceutical compositions for oral delivery of drugs |
| 06/15/2006 | US20060128740 Tricyclic androgen receptor modulator compounds and methods |
| 06/15/2006 | US20060128737 Androgen receptor agonists |
| 06/15/2006 | US20060128736 Camptothecin-carboxylate formulations |
| 06/15/2006 | US20060128734 N-(4-(4-(4-hydroxyphenylamino)-pyrimidin-6-yl)-oxyphenyl)-N'-(3-trifluoromethylphenyl)-urea; |
| 06/15/2006 | US20060128711 derivatives of ecteinascidins, particularly ecteinascidin 736, used for the treatment of lung, colon, kidney, prostate, cervical, ovarian, breast or pancreatic cancer, leukaemia or melanoma in mammals; reduced systemic toxicity and improved pharmacokinetics |
| 06/15/2006 | US20060128693 Pyrrolobenzodiazepines |
| 06/15/2006 | US20060128684 Anthranilic acid amide derivatives and their pharmaceutical use |
| 06/15/2006 | US20060128674 Induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; antiviral and antitumor agents |
| 06/15/2006 | US20060128672 Methods for the administration of amifostine and related compounds |
| 06/15/2006 | US20060128655 Use of hyaluronic acid or its derivatives to enhance delivery of antineoplastic agents |
| 06/15/2006 | US20060128645 Inhibition of proliferation and infiltration of brain tumor cells caused by expression of ampa-type glutamate receptor subunit |
| 06/15/2006 | US20060128640 Combination of a taxane and a cyclin-dependent kinase |
| 06/15/2006 | US20060128639 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 06/15/2006 | US20060128638 Treating atheroma, tumors and other neoplastic tissue; treating atherosclerotic inflammation; forming a complexes with a reducing agent, penetrate and accumulate more rapidly in tumor cells, plaque, increase drug in intracellular concentration; increase photosensitivity |
| 06/15/2006 | US20060128636 Breast cancer resistance protein (bcrp) inhibitor |
| 06/15/2006 | US20060128633 Colchinol derivatives as vascular damaging agents |
| 06/15/2006 | US20060128631 Peptides and derivatives thereof showing cell attachment, spreading and detachment activity |
| 06/15/2006 | US20060128629 Angiogenesis inhibitors, antitumor agents |
| 06/15/2006 | US20060128624 Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration |
| 06/15/2006 | US20060128619 Therapeutic use of modulators of notch |
| 06/15/2006 | US20060128607 Method for inhibiting "melanoma inhibitory activity" mia |
| 06/15/2006 | US20060128606 Fibrils |
| 06/15/2006 | US20060127903 Marker for cancer |
| 06/15/2006 | US20060127900 Method for detecting increased susceptibility to tumors |
| 06/15/2006 | US20060127896 Materials and methods for treating cancer |
| 06/15/2006 | US20060127895 Use of c-jun or c-jun activating agents such as uv or c-jun n-terminal kinases (junks) for treating cancer |